| Systemic Lupus Erythematosus Research | Lifetime | 13 | US 4 | 99.87 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 35 | US 26 | 99.89 |
| Natural Compounds in Disease Treatment | Lifetime | 1 | US 1 | 99.66 |
| T-cell and B-cell Immunology | Lifetime | 41 | US 31 | 99.90 |
| Immune Cell Function and Interaction | Lifetime | 74 | US 51 | 99.88 |
| Immunotherapy and Immune Responses | Lifetime | 84 | US 57 | 99.84 |
| Immune Response and Inflammation | Lifetime | 119 | US 60 | 99.64 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 99 | US 47 | 99.39 |
| Cell Adhesion Molecules Research | Lifetime | 180 | US 97 | 99.29 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 107 | US 52 | 99.17 |
| Inflammatory mediators and NSAID effects | Lifetime | 108 | US 56 | 99.10 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 123 | US 39 | 99.41 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 170 | US 82 | 98.63 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 179 | US 57 | 98.72 |
| Diabetes and associated disorders | Lifetime | 457 | US 183 | 98.15 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 99 | US 38 | 97.48 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 616 | US 283 | 98.43 |
| CAR-T cell therapy research | Lifetime | 710 | US 419 | 98.10 |
| Chemokine receptors and signaling | Lifetime | 258 | US 116 | 96.12 |
| Mast cells and histamine | Lifetime | 357 | US 135 | 96.37 |
| Natural product bioactivities and synthesis | Lifetime | 773 | US 91 | 96.85 |
| Case Reports on Hematomas | Lifetime | 94 | US 31 | 94.11 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 246 | US 106 | 92.66 |
| Urticaria and Related Conditions | Lifetime | 652 | US 199 | 95.08 |
| Salivary Gland Disorders and Functions | Lifetime | 577 | US 192 | 94.45 |
| Celiac Disease Research and Management | Lifetime | 725 | US 167 | 92.30 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 87 | US 31 | 98.34 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 110 | US 26 | 93.75 |
| T-cell and B-cell Immunology | 2021-2025 | 248 | US 107 | 93.30 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 924 | US 293 | 89.18 |
| Lipid metabolism and disorders | 2021-2025 | 375 | US 89 | 75.44 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 474 | US 55 | 75.88 |
| Case Reports on Hematomas | 2021-2025 | 120 | US 34 | 69.32 |
